全球尿道狹窄治療設備市場:當前分析和預測(2021-2027)
市場調查報告書
商品編碼
1114702

全球尿道狹窄治療設備市場:當前分析和預測(2021-2027)

Urethral Stricture Treatment Devices Market: Current Analysis and Forecast (2021-2027)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 229 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

在預測期間(2021-2027 年),全球尿道狹窄治療設備市場規模預計將以 6% 左右的複合年增長率增長。

良性前列腺增生 (BPH) 和神經源性膀胱患病率的增加以及老年人口的迅速增加是尿道狹窄治療設備廣泛採用的原因之一。此外,技術的快速進步也有望推動尿道狹窄治療設備市場。

本報告研究了全球尿道狹窄治療設備市場,並提供了全面的信息,包括市場洞察、市場趨勢、競爭情景和公司概況。

內容

第一章市場介紹

  • 市場定義
  • 限制
  • 利益相關者
  • 報告中使用的貨幣

第二章研究方法或假設

  • 尿道狹窄治療設備市場研究過程
  • 尿道狹窄治療裝置市場研究方法論
  • 預測方法
  • 受訪者個人資料
  • 尿道狹窄治療裝置市場研究的主要目標

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對全球尿道狹窄治療設備市場的影響

第 6 章全球尿道狹窄治療設備市場收入(2019-2027)

第 7 章市場洞察:按產品類型

  • 尿道擴張器
  • 尿道支架
  • 尿道球囊擴張導管
  • 導尿管

第 8 章市場洞察:按狹窄部位

  • 正面
  • 後面

第 9 章市場洞察:按最終用戶分類

  • 醫院
  • 專科診所
  • 其他

第 10 章市場洞察:按地區劃分

  • 北美尿道狹窄治療裝置市場
    • 美國
    • 加拿大
    • 北美其他地區
  • 歐洲尿道狹窄治療裝置市場
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太尿道狹窄治療儀市場
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 亞太地區其他地區
  • 其他

第11章尿道狹窄治療裝置市場動態

  • 市場驅動力
  • 市場挑戰
  • 影響分析

第 12 章尿道狹窄治療設備市場機遇

第 13 章尿道狹窄治療裝置市場趨勢

第 14 章。法律和監管框架

第十五章需求側和供給側分析

  • 需求方分析
  • 供應方分析

第 16 章價值鏈分析

第 17 章衝突場景

  • 競爭格局
    • 波特五力分析

第十八章公司概況

  • Boston Scientific Corporation
  • Laborie
  • Cook Medical
  • B.Braun Melsungen AG
  • Allium Medical
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Pnn Medical A/S
  • Med pro Medical B.V.
  • Coloplast

第19章 免責事項

簡介目錄
Product Code: UMHE21927

Global Urethral Stricture Treatment Devices Market is anticipated to grow with an elevated CAGR of around 6% over the forecast period (2021-2027).

Urethral stricture is a condition in which the urethral opening becomes narrow due to injuries, scars, or infection. A stricture obstructs the free flow of the urine through the urethra. Therefore, urethral stents, catheters, or dilators are employed to maintain the flow as the urethral stricture treatment. The growing adoption of urethral stricture treatment devices can be attributed to the rising prevalence of benign prostatic hyperplasia & neurogenic bladder coupled with a rapidly growing geriatric population. According to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The number of elderly people is expected to double again by 2050 and reach nearly 2.1 billion worldwide. Furthermore, with rapid advancements in technology, many of the industry players are focusing on launching new products in the market to expand their product portfolio, which will drive the market for urethral stricture treatment devices globally. For example, in December 2021, The US Food and Drug Administration (FDA) approved the Urotronic Optilume Urethral Drug Coated Balloon to treat urethral strictures in males. It serves as an alternative to traditional endoscopic stricture treatments for men suffering from urethral strictures. Boston Scientific Corporation, Laborie, Cook Medical, B.Braun Melsungen AG, Allium Medical, Becton, Dickinson and Company, Teleflex Incorporated, Pnn Medical A/S, Med pro Medical B.V., and Coloplast, are some of the prominent players operating in the urethral stricture treatment devices market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with urethral stricture treatment devices.

Insights Presented in the Report

"Amongst Product Type, urethral balloon dilation catheters segment holds the major share"

Based on product type, the urethral stricture treatment devices market is segmented into urethral dilators, urethral stents, urethral balloon dilation catheters, and urinary catheters. The urethral balloon dilation catheters segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as it is well-tolerated, safe, and offers various advantages such as minimal complications, less morbidity, and technically less challenging to perform.

"Amongst Stricture Location, anterior segment holds the major share"

Based on stricture location, the urethral stricture treatment devices market is divided into anterior and posterior. The anterior segment occupied the major share of the urethral stricture treatment devices market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years as anterior urethral strictures are the most common and occur anywhere along the urethra from the urethral meatus at the tip of the penis, in the penile urethra or in the bulbar urethra, which is located behind the scrotum in males.

"Amongst End-Users, hospitals segment holds the major share"

Based on end-users, the market is fragmented into hospitals, specialty clinics, and others. In 2020, the hospitals segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increasing number of hospitals and a surge in the number of urology surgeries in the hospital setting. Also, the presence of well-trained healthcare professionals, well-established infrastructure, and availability of technologically advanced devices in hospitals are some of the factors contributing to the growth of this segment. However, specialty clinics are also likely to witness lucrative growth during the forecast period.

"North America represents one of the largest markets of Urethral Stricture Treatment Devices market"

For a better understanding of the market dynamics of the Urethral Stricture Treatment Devices market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the urethral stricture treatment devices market industry in 2020 owing to the strong healthcare infrastructure and growing adoption of urethral stricture treatment devices in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global urethral stricture treatment devices market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Urethral Stricture Treatment Devices Market
  • 2.2. Research Methodology of the Urethral Stricture Treatment Devices Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Urethral Stricture Treatment Devices Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL URETHRAL STRICTURE TREATMENT DEVICES MARKET COVID-19 IMPACT

6 GLOBAL URETHRAL STRICTURE TREATMENT DEVICES MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Urethral Dilators
  • 7.2. Urethral Stents
  • 7.3. Urethral Balloon Dilation Catheters
  • 7.4. Urinary Catheters

8 MARKET INSIGHTS BY STRICTURE LOCATION

  • 8.1. Anterior
  • 8.2. Posterior

9 MARKET INSIGHTS BY END-USERS

  • 9.1. Hospitals
  • 9.2. Specialty Clinics
  • 9.3. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Urethral Stricture Treatment Devices Market
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Urethral Stricture Treatment Devices Market
    • 10.2.1. Germany
    • 10.2.2. France
    • 10.2.3. United Kingdom
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia Pacific Urethral Stricture Treatment Devices Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. Rest of Asia Pacific
  • 10.4. Rest of World Urethral Stricture Treatment Devices Market

11 URETHRAL STRICTURE TREATMENT DEVICES MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 URETHRAL STRICTURE TREATMENT DEVICES MARKET OPPORTUNITIES

13 URETHRAL STRICTURE TREATMENT DEVICES MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

  • 18.1. Boston Scientific Corporation
  • 18.2. Laborie
  • 18.3. Cook Medical
  • 18.4. B.Braun Melsungen AG
  • 18.5. Allium Medical
  • 18.6. Becton, Dickinson and Company
  • 18.7. Teleflex Incorporated
  • 18.8. Pnn Medical A/S
  • 18.9. Med pro Medical B.V.
  • 18.10. Coloplast

19 DISCLAIMER